瘤微环境中的三级淋巴体结构和肺癌免疫疗法
Mei Xie1, Xuwen Lin1, Xinyu Bao2
1Department of Respiratory and Critical Care, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, People's Republic of China.
Archivos de bronconeumologia
|August 22, 2024
概括
三级淋巴体结构 (TLS) 是肺癌中抗瘤免疫的关键. 了解瘤微环境 (TME) 中的TLS可以优化免疫疗法反应并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 免疫检查点抑制剂已经彻底改变了肺癌的治疗方法.
- 患者对免疫治疗的反应有很大的不同.
- 三级淋巴体结构 (TLS) 是瘤中的免疫细胞聚合物,对抗瘤反应至关重要.
研究的目的:
- 审查TLS的组成,形成和检测.
- 总结TLS在肺癌免疫治疗中的作用.
- 讨论TLS诱导作为一种治疗策略.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 综合有关TLS的现有数据.
- 分析TLS在瘤微环境 (TME) 中的作用.
主要成果:
- 在TME中TLS的存在与肺癌的良好预后和免疫治疗反应相关.
- TLS是抗瘤免疫活动的部位.
- 了解TLS动态对于免疫疗法优化至关重要.
结论:
- 在肺癌中,TLS是抗瘤免疫反应的关键组成部分.
- 向TLS诱导可能会提高免疫治疗的疗效.
- 对TLS的进一步研究对于推进肺癌治疗至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493